Loading ...
Jack Berlin
Business & Economics
Business News
15
0
Try Now
Log In
Pricing
<p>Healthcare Coverage Overview Deloitte Corporate Finance LLC April 2015 - 2 - © 2015. For information, contact Deloitte Development LLC. About Deloitte: Leading Global and U.S. Advisor * Deloitte Corporate Finance LLC, member FINRA, is a wholly-owned subsidiary of Deloitte Financial Advisory Services LLP. Investment banking products and services within the United States are offered exclusively through DCF. DCF operates within one of the world’s leading professional services organizations, Deloitte Touche Tohmatsu Limited (“DTTL”), which offers broad-based advisory services with an integrated approach to leading organizations around the world. Deloitte Touche Tohmatsu Limited 2014 Global Revenue: $34 Billion 210,000+ employees Deloitte & Touche LLP Deloitte Consulting LLP Deloitte Financial Advisory Services LLP Deloitte Tax LLP Deloitte Corporate Finance LLC* Other FAS Services Global access and execution capabilities – A global network of more than 2,400 corporate finance professionals with offices in over 60 countries providing clients with access to regional market insights and intelligence around the world. Integrated transaction solutions – Together with member firms, provider of collaborative execution capabilities addressing the range of transactions and related financial, operational, human capital, information technology, tax and accounting issues. Strong reputation – Brand known for integrity and credibility across the globe helping increase opportunities for our clients. Knowledge and experience – Seasoned professionals with practical knowledge of the industry, actively involved through the entire deal process to drive transaction timing and value. Deloitte CRG Business Valuation Real Estate Consulting Engineering and Construction Consulting Deloitte Forensic Deloitte Analytics - 3 - © 2015. For information, contact Deloitte Development LLC. About Deloitte Corporate Finance LLC DCF is a leading M&A advisor with global execution capabilities that leverages deep transaction experience to deliver innovative services and superior results to clients operating across eight core industry groups. Nationwide Coverage with Global Access and Reach The DCF Difference Worldwide: 2,400 professionals across 60 countries United States: 135 professionals based in 8 cities Atlanta Charlotte Chicago Dallas Detroit Houston Los Angeles New York Comprehensive Service Offerings Outstanding Reputation Deep Industry Insight Sellside and Divestiture Buyside Capital Raising and Advisory Corporate and Board Advisory Employee Stock Ownership Plan (ESOP) Combined with member firms of Deloitte Touche Tohmatsu Limited, serves 79 percent of the Fortune Global 500®. Ranked as the No. 3 global middle- market financial advisor in 2014.(1) Aerospace & Defense Financial Services Business Services General Industrials Consumer & Retail Healthcare & Life Sciences Energy & Resources Technology, Media & Telecom Middle Market Focus Low B re ad th o f I nd us tr y & In te rn at io na l A cc es s High High Low Boutique Banks Bulge Bracket Banks Footnote: (1) Thomson Financial, 12 months ending 12/31/14. © 2015. For information, contact Deloitte Development LLC. - 4 - DCF’s broad offering of services and highly-relevant transaction experience allows us to provide our clients with an objective perspective on shareholder alternatives. DCF Service Offering DCF Investment Banking Services Sales and Divestitures Acquisition, Joint Venture and Alliance Capital Advisory Capital Raising Corporate Development Advisory Board Advisory Pre-sale due diligence Identify buyers Prepare confidential memorandum Clear the market Deal negotiation Coordinate closing Define acquisition goals Target evaluation Transaction modeling Finance assistance Deal negotiation Coordinate closing Refinancings Acquisitions, project financings, disposals, and mergers Restructurings General financial advisory Assess alternative structures Create a plan Identify appropriate sources Transaction modeling Deal negotiation Coordinate closing Strategic options Buyer/Target search Complex financial modeling Full transaction execution support Fairness opinions Prioritize shareholder objectives Special committee financial advisory Strategic alternatives M&A Services Tax Services (Deloitte Tax LLP) (Deloitte Consulting LLP) M&A Strategy and Post Merger Integration Services (Deloitte Consulting LLP) M&A Transaction Services (Deloitte & Touche LLP) (Deloitte Tax LLP) © 2015. For information, contact Deloitte Development LLC. - 5 - Deloitte Life Sciences & Healthcare Expertise Life Sciences & Healthcare Industry Expertise Example M&A Market Recognition Forrester Research “Deloitte provides a highly compelling mergers and acquisitions (M&A) services proposition through its broad portfolio and business expertise, underpinned by a consistent and integrated go-to-market strategy.” “Deloitte provides an M&A services portfolio of compelling global breadth and global reach.” “Clients value Deloitte’s customer-focused and flexible service model with strong M&A capabilities and thorough understanding of complex functional processes.” Ambulatory Surgery Centers Contract Manufacturers Disease Management Healthcare Information Technology Healthcare Services Laboratory Services Life Sciences Managed Care Medical Information Services Medical Supplies and Distribution Pharmacy Benefit Management Physician Practice Management Specialty Pharmacies Transcription, Billing, and Coding Urgent Care Centers DCF provides client-centered M&A advisory and execution services across a wide breadth of verticals within the life sciences and healthcare industry. © 2015. For information, contact Deloitte Development LLC. - 6 - Deloitte Life Sciences & Healthcare Qualifications Deloitte has 9,400 professionals in the United States that offer healthcare industry services and solutions across strategy, operations, technology and human capital, tax, risk, security and privacy, and financial advisory. Deloitte’s Life Sciences and Healthcare Practice serves more than 95% of the Fortune 500® life sciences and healthcare companies, as well as the following: – More than 90% of the Honor Roll Hospitals (as ranked by U.S. News & World Report) – 9 of the 10 Largest Healthcare Systems (as ranked by Modern Healthcare) – 9 of the 10 Largest For-Profit Healthcare Systems (as ranked by Modern Healthcare) – The Majority of the Largest Secular Not-for-Profit Healthcare Systems (as ranked by Modern Healthcare) – More than 80% of the Best Children's Hospitals (as ranked by U.S. News & World Report) Physicians and Healthcare Systems Managed Care and Pharmacy Benefits Managers – Nearly 85% of the Top 25 U.S. Health Plans (as ranked by AIS's Directory of Health Plans) – Nearly 60% of the Nation's Blue Cross Blue Shield Plans – More than 75% of the Top 25 Managed Care Organizations (as ranked by HealthLeaders) – 6 of the Top 10 Pharmacy Benefits Managers (as ranked by Pharmacy Benefit Management Institute) Pharmaceutical Manufacturers and Biotechnology Companies – Nearly 90% of the 15 Largest Pharmaceutical Manufacturers (as ranked by Med Ad News) – 6 of the 10 Largest Biotechnology Companies (as ranked by Med Ad News) – 9 of the Top 10 Medical Device Manufacturers (as ranked by Medical Product Outsourcing) © 2015. For information, contact Deloitte Development LLC. - 7 - Deloitte Life Sciences & Thought Leadership The Deloitte Center For Health Solutions (“DCHS”) is Deloitte’s health services research arm, and seeks to inform healthcare clients about emerging trends, challenges, and opportunities using rigorous, up-to-date research. The Center employs a wealth of industry experts who author nationally acclaimed healthcare industry publications. Bill Copeland Bill Copeland is the U.S. Life Sciences and Healthcare Leader for Deloitte LLP and the sector leader of the practice's health plans group. A 26-year veteran with Deloitte, Bill has advised some of the organization's largest healthcare industry clients on their most strategic and transformative events, including mergers, affiliations, new business initiatives and financial and operational turnaround plans. He has also led projects around corporate governance and new management processes that link strategy to metrics and board oversight. Vice Chairman U.S. Life Sciences & Healthcare Leader Deloitte LLP Health Reform Memos On a weekly basis, DCHS publishes the Monday Memo: Health Reform Update, which highlights news from the previous week on various healthcare reform efforts and implications for stakeholders. 2013 Survey of U.S. Physicians: Perspectives about Healthcare Reform and the Future of the Medical Profession The Deloitte 2013 Survey of U.S. Physicians presents key findings on physician perspectives about health care reform and the future of the medical profession. DCHS offers two reports: “2013 Survey of U.S. Physicians: Perspectives of health care reform and the future of the medical” and “Physician adoption of health information technology: Implications for medical practice leads and business partners.” Breaking Constraints: Can Incentives Change Consumer Health Choices? Innovative incentive programs may well help individuals overcome the inertia that limits engagement in wellness programs, disrupting the trade-offs people make when pursuing healthcare goals. This issue brief explores factors driving employer interest in incentivizing participation in worksite wellness programs. What’s Around the Corner for the Health Care Industry Major elements of the ACA are scheduled to be implemented in 2013, including health insurance exchange (HIX) open enrollment, and new rates for small groups. But healthcare cost containment will continue as a primary focus for the federal government, states, employers, and consumers. This piece shares views on what developments industry stakeholders could expect within the next year and beyond. The Affordable Care Act of 2010: May 2013 Progress Report What are the major elements of the health reform law, the specific indicators of its progress, and the status of its implementation? This tool was created by DCHS to engage clients interested in learning more about the major elements of the Affordable Care Act (ACA). The report includes talking points and a suggested timetable to foster a dialogue with clients about the strategies necessary to survive in an ever-evolving, value- driven, cost-containment environment. Survey Says Health Plans Advance Retail Capabilities: Highlights from Deloitte’s 2013 Health Plan Retail Capability Survey “Retail” is a hot topic in the health insurance industry today, and for good reason. From the creation of health insurance marketplaces, to the continued growth in Medicaid and Medicare, to the defined contribution movement and the rise of private exchanges, the sale and delivery of health insurance is requiring an increasing focus on the individual consumer. Leadership Recent Publications Leadership and Talent: Enabling Radical Cost Reduction through Effective Organizational Alignment To remain competitive in the marketplace, healthcare providers must accommodate healthcare consumers, third party payors, and governmental regulators who increasingly demand higher quality treatment at lower costs. Additionally, recent and forthcoming regulations provide concrete incentives to minimize costs of treatment, such as lower Medicare and Medicaid reimbursement levels. - 8 - © 2015. For information, contact Deloitte Development LLC. Deloitte’s Connectivity Across the Healthcare Landscape Deloitte’s cross-functional relationships and enormous reach throughout the healthcare industry routinely enhance DCF’s execution of M&A transactions because of our unique perspective and informed judgment. Physician Staffing RCM Outsourcing Hospitals A Sample Of The Industry Leaders That We Work With… - 9 - © 2015. For information, contact Deloitte Development LLC. Deloitte Offers Leading HCIT Expertise Deloitte Corporate Finance regularly leverages its access to one of the leading Healthcare IT consulting practices in the country accessing its network and expertise within the industry. Deloitte has won several best in KLAS awards for revenue cycle and clinical transformation from KLAS, a leading healthcare IT vendor performance monitoring company. “Deloitte is the best consulting firm I have dealt with… “Deloitte identified several millions of dollars of benefit that would be available to us. That estimate ended up being even higher than what they initially projected, so it helped fund their work.” “We picked Deloitte because they understand the mission of working with safety net providers. They understand our mission, what we are trying to do, and the kinds of patients we are working with.” - KLAS commentary Deloitte has also received several accolades from Kennedy and Modern Healthcare. “Deloitte brings deep and broad capabilities to healthcare clients; its balance of financial, technical, and industry consultants allows the firm to respond to more complex and comprehensive engagements.” - 10 - © 2015. For information, contact Deloitte Development LLC. Healthcare & Life Sciences Group Experience Market Segment Focus DCF’s Healthcare & Life Sciences Group combines extensive transactional experience, long-term client relationships, and in-depth industry knowledge to effectively advise our clients in today’s market environment. Anesthesia Services Contract Manufacturing Contract Research Organization Healthcare Clinics Healthcare Information Technology Healthcare Services Hospitals Laboratory Services Managed Care/PBM Medical Information Services Medical Supplies & Distribution Pharmacy Physician Practice Management Transcription, Billing, & Coding Veterinary Dave Vorhoff Co-Head of Healthcare Group Prior Experience - President, Managing Director, and head of healthcare group for McColl Partners. - Managing Director for Banc of America Securities New York and NationsBanc Montgomery Securities New York. Ron Rivera Co-Head of Technology Group Prior Experience - Managing Director and head of technology group for McColl Partners. - Various positions with SG Cowen Securities, Wachovia Securities, and SunTrust Robinson Humphrey. - 11 - © 2015. For information, contact Deloitte Development LLC. *References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC. Select DCF Transaction in HCIT Integrated Healthcare Solutions, Inc. (“IHS”) is a leading single-source provider of practice management solutions to healthcare providers nationwide. IHS offers electronic health records, enterprise practice management, revenue cycle management, interoperability/clinical data-sharing, and data center services. McColl Partners advised IHS on a mezzanine debt raise to launch several strategic growth initiatives. HealthSCOPE Benefits, Inc. (“HealthSCOPE”) is a leading provider of claims administration and health management services to self-funded employers throughout the United States. McColl Partners received multiple term sheets from various capital providers and assisted HealthSCOPE in choosing the optimal partner to suit the company’s needs. McColl Partners added significant value throughout the marketing process by properly positioning the company’s investment merits and creating a competitive process that resulted in terms that exceeded the clients’ expectations. The undersigned acted as financial advisor to HealthSCOPE.* has completed a recapitalization with The undersigned acted as financial advisor to IHS.* has completed a recapitalization with Sale of Claims Administration Services Business Debt Recapitalization Of Practice Management Software Vendor Vendor Credentialing Service ( “VCS”) is a rapidly growing healthcare information technology (“IT”) company that provides web-based vendor credentialing to hospitals and their vendor suppliers. McColl Partners identified untapped markets that could be exploited by VCS’s unique business model and highlighted all facets of the company’s product and service offering and unique business model to drive significant acquiror interest. The undersigned acted as financial advisor for the transaction has completed a recapitalization with Sale of Vendor Credentialing Technology Company - 12 - © 2015. For information, contact Deloitte Development LLC. Select DCF Transaction in HCIT Project Racecar (“Racecar”) is the premier global provider of business process outsourcing solutions to healthcare organizations nationwide. DCF is engaged to identify targets in the revenue cycle management and anesthesia billing / practice management industries. DCF has since identified more than 50 targets, two of which Racecar has entered advanced discussions and is negotiating definitive agreements. Project Gatsby (“Gatsby”) is a multi-specialty group practice with more than 2,000 physicians in over 100 medical and surgical specialties closely affiliated with a regional hospital network of more than 10 facilities. DCF has been engaged to advise Gatsby in evaluating and structuring a potential carve-out and sale of the group practice’s MSO. Carve-out and Sale of Hospital-Based Physician MSO Sale of Comprehensive RCM IT Solutions Provider Acquisition Of Anesthesia Billing and Practice Management Companies Project Xenon (“Xenon”) is a leading provider of tech-enabled RCM solutions that span nearly the entire RCM spectrum, serving more than 7,000 physicians across the United States. Xenon’s proprietary technology platform boasts a sophisticated rules engine for claims documentation and filing. DCF has been engaged to assist Xenon in the evaluation of several strategic alternatives. Project Xenon The undersigned is acting as financial advisor to Project Xenon Project Racecar The undersigned is acting as financial advisor to Project Racecar Project Gatsby The undersigned is acting as financial advisor to Project Gatsby - 13 - © 2015. For information, contact Deloitte Development LLC. Select DCF Transaction in HCIT Project Lassie (“Lassie”) is a leading provider of back-end RCM solutions including: extended business office, self-pay and insurance, and bad debt collection services. Lassie has engaged DCF to identify the optimal operating and financial partner to support future growth. Sale of Comprehensive EHR Software Provider Sale of Revenue Cycle Management Services Provider Project Rosetta (“Rosetta”) is a leading provider of open source EHR software built to improve efficiencies for clinical and administrative users in the U.S. government, VA hospital network, and commercial facilities. Rosetta has engaged DCF to assist the company in exploring strategic alternatives. Project Rosetta The undersigned is acting as financial advisor to Project Rosetta Project Lassie The undersigned is acting as financial advisor to Project Lassie - 14 - © 2015. For information, contact Deloitte Development LLC. Healthcare & Life Sciences Group Select Transactions *References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC. HCIT has completed a recapitalization with The undersigned acted as financial advisor to Vendor Credentialing Service, LLC.* The undersigned acted as financial advisor to Integrated Healthcare Solutions, Inc.* has completed a recapitalization with has been acquired by The undersigned acted as financial advisor to Fallon Community Health Plan. The undersigned acted as financial advisor to FlexBen Corporation.* has been acquired by has acquired The undersigned acted as financial advisor to Stryker Corporation. The undersigned acted as financial advisor to Partners Rx Management, LLC. has been acquired by The undersigned acted as financial advisor to Career Step, LLC.* has completed a management recapitalization with The undersigned acted as financial advisor to etrials, Inc.* has merged with to form etrials Worldwide, Inc. The undersigned acted as financial advisor to HealthSCOPE.* has completed a recapitalization with has been acquired by Coventry Health Care, Inc. The undersigned acted as financial advisor to Altius Health Plans, Inc.* has completed a recapitalization with The undersigned acted as financial advisor to ScriptSave.* Outsourced Services has completed a merger with The undersigned acted as financial advisor to SRI/Surgical Express, Inc.* The undersigned acted as financial advisor to TrustHouse Services Group, Inc.* has been acquired by The undersigned acted as financial advisor to TrustHouse Services Group, Inc.* a portfolio company of has acquired The undersigned acted as financial advisor to KLMK Group, Inc.. has been acquired by a portfolio company of The undersigned acted as financial advisor to TrustHouse Services Group, Inc.* has acquired and its wholly owned subsidiary The undersigned acted as financial advisor to TrustHouse Services Group, Inc.* has acquired The undersigned acted as financial advisor to TrustHouse Services Group, Inc.* a portfolio company of has acquired has acquired The undersigned acted as financial advisor to Stryker Corporation. - 15 - © 2015. For information, contact Deloitte Development LLC. Healthcare & Life Sciences Group Select Transactions (Cont’d) Home Health/Rehabilitation *References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC. Physician Practice Management Dental Practice Management The undersigned acted as financial advisor to Riverchase Dermatology and Cosmetic Surgery.* has completed a recapitalization with The undersigned acted as financial advisor to Radiation Oncology Associates, PC and ROA Associates, LLP. has entered into a partnership arrangement with The undersigned acted as financial advisor to MIRO/MCCI. has been acquired by The undersigned acted as financial advisor to Greater Houston Anesthesiology P.A. a portfolio company of has partnered with Welsh, Carson, Anderson & Stowe The undersigned acted as financial advisor to Children’s Dentistry and Family Orthodontics.* has completed a recapitalization with has completed a recapitalization with The undersigned acted as financial advisor to Kids Care Dental Group.* has completed a recapitalization The undersigned acted as financial advisor to Dentistry for Children, P.C.* Hospitals The undersigned acted as financial advisor to Columbia/HCA Healthcare Corp. entered into a joint venture with Columbia/HCA Healthcare Corporation Hertzler Clinic, P.A. The undersigned acted as financial advisor to Yale-New Haven Hospital. has acquired Quorom Health Group, Inc. The undersigned acted as financial advisor to Northwest Health Systems, Inc. has been acquired by The undersigned acted as financial advisor to United Medical Corporation. an affiliate of has been acquired by United Medical Corporation The undersigned acted as financial advisor to United Medical Corporation an affiliate of has sold several behavioral hospitals and related assets to United Medical Corporation The undersigned acted as financial advisor Nebraska Heart Institute and Heart Hospital. has acquired The undersigned acted as financial advisor to Senior Select Home Health Services and AHC Peronal Assisted Services have been acquired by subsidiaries of The undersigned acted as financial advisor to Healthtrax, Inc.* William Blair Capital Partners has completed a recapitalization with has obtained for the acquisition of Therapy Management Services, Inc. $29,000,000 Private Financing The undersigned acted as financial advisor to EnduraCare, LLC.* The undersigned acted as financial advisor to Premier Hospice & Palliative Care. a portfolio company of has acquired have received an investment from The undersigned acted as financial advisor to Accelerated Care Plus Corp. - 16 - © 2015. For information, contact Deloitte Development LLC. Healthcare & Life Sciences Group Select Transactions (Cont’d) *References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC. Devices/Equipment has been acquired by The undersigned acted as financial advisor to Crown Therapeutics, Inc. Crown Therapeutics, Inc. Gateway HomeCare, Inc. The undersigned acted as financial advisor to SP Industries, Inc.* has been acquired by has completed a merger with The undersigned acted as financial advisor to SRI/Surgical Express, Inc.* The undersigned acted as financial advisor to Delphi Medical Systems Corporation.* has acquired has been acquired by The undersigned acted as financial advisor to Elastic Therapy, Inc.* a portfolio company of The undersigned acted as financial advisor to Burle Industries, Inc.* has been acquired by a portfolio company of The undersigned acted as financial advisor to Home Health Medical Equipment, Inc. d/b/a AG Industries.* has been acquired by a portfolio company of Madison Capital Partners The undersigned acted as financial advisor to The Marena Group, Inc.* has completed a recapitalization with Distribution/Supplies has completed a recapitalization with The undersigned acted as financial advisor to The SCOOTER Store, Ltd.* has completed a recapitalization with The undersigned acted as financial advisor to Woodbury Health Products.* The undersigned acted as financial advisor to Meridian Healthcare Group. has sold certain assets to has been acquired by The undersigned acted as financial advisor to NationsHealth, Inc. Veterinary has completed a recapitalization with The undersigned acted as financial advisor to Diamondback Drugs, LLC.* The undersigned acted as financial advisor to the Audit Committee of the Board of Directors of VCA Antech, Inc. a subsidiary of has acquired has completed a management recapitalization with The undersigned acted as financial advisor to Royal Pet Supplies, Inc.* Quarry Capital Management - 17 - © 2015. For information, contact Deloitte Development LLC. Healthcare & Life Sciences Group Select Transactions (Cont’d) The undersigned acted as financial advisor to International Vitamin Corporation. has acquired the of *References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC. Pharmacy Pharma/Contract Research The undersigned acted as financial advisor to Zymed Laboratories Inc.* has been acquired by The undersigned acted as financial advisor to Diversified Pharmacy Group.* has been acquired by The undersigned acted as financial advisor to Cox Nuclear Pharmacies.* has been acquired by COX NUCLEAR PHARMACIES The undersigned acted as financial advisor to Coastal Pharmacy Services, Inc.* has been acquired by The undersigned acted as financial advisor to ITS Pharmacy, Inc. a portfolio company of has acquired The undersigned acted as financial advisor to Medicap Pharmacies, Inc. has been acquired by Management with financing provided by Homeland Savings Bank, FSB Senior Secured Facilities and Penninsula Capital Partners L.L.C. Senior Subordinated Notes Nutritional Supplements/ Nutraceuticals The undersigned acted as financial advisor to Bio-Engineered Supplements & Nutrition, Inc.* has been acquired by The undersigned acted as financial advisor to the Special Committee of USANA.* Nutritional Supplement Business Fairness Opinion has completed a recapitalization with The undersigned acted as financial advisor to Diamondback Drugs, LLC.* has acquired The undersigned acted as financial advisor to Altana, Inc. Prescription Dermatology Product Portfolio of GlaxoSmithKline The undersigned acted as financial advisor to Neways International.* has been acquired by The undersigned acted as financial advisor to Carolina Medical Products Company.* received an investment from Pharma Licensing, J.V., and Valuation has entered into a partnership arrangement with The undersigned acted as financial advisor to BioMS Medical. has entered into a joint venture with The undersigned acted as financial advisor to SemBioSys Genetics Inc. has received The undersigned acted as financial advisor to Resverlogix Corp. Valuation Services has entered into a strategic partnership with The undersigned acted as financial advisor to SemBioSys Genetics Inc. and - 18 - © 2015. For information, contact Deloitte Development LLC. Senior Debt Private Capital Solutions Group Subordinated Debt Preferred Equity > $6.0 Billion Specialized product experience with extensive lender and investor relationships. Regular dialogue with over 300 financing sources. − International and U.S. commercial banks − Finance companies − Hedge funds − Business development corporations − Mezzanine funds Ability to create competitive processes among potential lenders and investors. Reputation for innovative structures and completion of complex situations, including highly leveraged transactions and “challenged” credit deals. DCF consistently has multiple engagements in the market and maintains regular dialogue with a large universe of capital providers that enables us to stay close to an ever-changing market. DCF Advantage Private Capital Solutions - 19 - © 2015. For information, contact Deloitte Development LLC. DCF’s Financial Sponsors Group focuses on providing superior service and exceptional results through a high-touch, consistent coverage strategy with financial sponsors. The Financial Sponsors Group maintains dialogue with over 300 financial sponsors in a wide variety of markets throughout the United States and internationally. DCF has real-time information on which groups are interested in recapitalization transactions. Regular dialogue with these financial sponsors provides meaningful insight into the investment community’s interests in prospective acquisitions. Financial Sponsors Group Select Transactions has completed a recapitalization with The undersigned acted as financial advisor to American Importing Company, Inc.* The undersigned acted as financial advisor to Dymatize Enterprises, Inc.* has completed a recapitalization with The undersigned acted as financial advisor to Bailey International LLC.* __________________ has completed a recapitalization with The undersigned acted as financial advisor to KeyImpact Sales & Systems, Inc.* __________________ has received a minority investment from The undersigned acted as financial advisor to Vendor Credentialing Service, LLC.*. __________________ has completed a recapitalization with The undersigned acted as financial advisor to Carolina Medical Products Co.* __________________ received an investment from The undersigned acted as financial advisor to HealthSCOPE.* _________________ has completed a recapitalization with The undersigned acted as financial advisor to Royal Pet Supplies, Inc.* a portfolio company of a portfolio company of has been acquired by __________________ The undersigned acted as financial advisor to Kids Care Dental Group.* has completed a recapitalization with __________________ Financial Sponsors Group *References an engagement that was performed by personnel of McColl Partners, LLC prior to the acquisition by DCF of substantially all of the assets of McColl Partners, LLC. The undersigned acted as financial advisor to ScriptSave.* has completed a recapitalization with The undersigned acted as financial advisor to Cardell Cabinetry.* has completed a recapitalization with The undersigned acted as financial advisor to Enhanced Recovery Corporation.* has been acquired by The undersigned acted as financial advisor to Klein-Becker USA, LLC.* a brand of has been acquired by The undersigned acted as financial advisor to the estate of the sole shareholder of Hooters of America, Inc.* has been acquired by A consortium of private equity investors - 20 - © 2015. For information, contact Deloitte Development LLC. Copyright © 2012 Deloitte Development LLC. All rights reserved. About Deloitte Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. Deloitte Corporate Finance LLC (“DCF”), member FINRA, is a wholly owned subsidiary of Deloitte Financial Advisory Services LLP (“Deloitte FAS”). Deloitte FAS is a subsidiary of Deloitte LLP. Investment banking products and services within the United States are offered exclusively through DCF. Copyright © 2015 Deloitte Development LLC. All rights reserved. Member of Deloitte Touche Tohmatsu Limited </p>